1-2 of 2
João Farias
Close
Sort by
Journal Articles

Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma

Andrew Bruce McDonald, Estelle Verburgh, Manuel Gotti, Antonio Pinto, Jan Maciej Zaucha, Vladimir Ivanov, Vladimir Melnichenko, Heidi Mocikova, Muhit Ozcan, Caterina Patti, João Farias, Iara Zapparoli Goncalves, Olha Kuchkova, Jiří Mayer, Güray Saydam, Sarah Tomassetti, Kumudu Pathiraja, Katherine Elizabeth Ryland, Patricia Marinello, Wojciech Jurczak
Journal: Blood
Blood (2023) 142 (Supplement 1): 4442.
https://doi.org/10.1182/blood-2023-186800
Published: 2023
Journal Articles

Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)

PAUL Coppo, Michaël Bubenheim, Ygal Benhamou, Linus A. Voelker, Paul T. Brinkkoetter, Lucas Kühne, Paul N. Knoebl, Maria Eva Mingot, Maria Cristina Pascual Izquierdo, Javier De La Rubia, Julio Del Rio Garma, Shruti Chaturvedi, Camila Masias, Marshall Mazepa, X. Long Zheng, Gyorgy Sinkovits, Marienn Reti, Christopher J. Patriquin, Katerina Pavenski, Tiago Boechat, Joao Farias, Eduardo Flavio Oliveira Ribeiro, Michaela Larissa Lobo de Andrade, Agnès Veyradier, Bérangère Joly, Sr., Raïda Bouzid, Kazuya Sakai, Masanori Matsumoto, Ilaria Mancini, Pasquale Agosti, Flora Peyvandi, Matthew James Stubbs, Amjad Hmaid, Sobia Sharif, Tina Dutt, Spero Cataland, Bernhard Lammle, Marie Scully
Journal: Blood
Blood (2023) 142 (Supplement 1): 2636.
https://doi.org/10.1182/blood-2023-179316
Published: 2023